WallStreetZenWallStreetZen

NASDAQ: ATRA
Atara Biotherapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ATRA stock forecasts and price targets.

Forecast return on equity

Is ATRA forecast to generate an efficient return?

Company
N/A
Industry
130.75%
Market
-52.16%

Forecast return on assets

Is ATRA forecast to generate an efficient return on assets?

Company
N/A
Industry
47.72%

ATRA earnings per share forecast

What is ATRA's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.89-221.92%
Avg 2 year Forecast
$0.26-64.38%
ATRA's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ATRA revenue forecast

What is ATRA's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$119.6M-36.61%
Avg 2 year Forecast
$54.6M-71.08%

ATRA earnings growth forecast

How is ATRA forecast to perform vs Biotechnology companies and vs the US market?

Company
24.54%
Industry
5.16%
Market
15.29%
ATRA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ATRA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ATRA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ATRA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATRA$12.12N/AN/A
HYPD$14.98$2.00-86.65%Hold
IFRX$1.26$7.40+487.30%Strong Buy
QNCX$1.60$7.33+358.31%Strong Buy
NTRB$7.15N/AN/A
View Top Biotech Stocks

Atara Biotherapeutics Stock Forecast FAQ

What is ATRA's earnings growth forecast for 2025-2026?

(NASDAQ: ATRA) Atara Biotherapeutics's forecast annual earnings growth rate of 24.54% is forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.16%, and it is also forecast to beat the US market's average forecast earnings growth rate of 15.29%.

Atara Biotherapeutics's earnings in 2025 is $5,795,000.On average, 2 Wall Street analysts forecast ATRA's earnings for 2025 to be -$6,250,498, with the lowest ATRA earnings forecast at -$24,580,612, and the highest ATRA earnings forecast at $12,079,615.

In 2026, ATRA is forecast to generate $1,825,988 in earnings, with the lowest earnings forecast at -$2,458,061 and the highest earnings forecast at $6,110,038.

If you're new to stock investing, here's how to buy Atara Biotherapeutics stock.

What is ATRA's revenue growth forecast for 2025-2026?

(NASDAQ: ATRA) Atara Biotherapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 86.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.

Atara Biotherapeutics's revenue in 2025 is $188,667,000.On average, 1 Wall Street analysts forecast ATRA's revenue for 2025 to be $839,954,627, with the lowest ATRA revenue forecast at $839,954,627, and the highest ATRA revenue forecast at $839,954,627.

In 2026, ATRA is forecast to generate $383,176,626 in revenue, with the lowest revenue forecast at $383,176,626 and the highest revenue forecast at $383,176,626.

What is ATRA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ATRA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 47.72%.

What is ATRA's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: ATRA) Atara Biotherapeutics's current Earnings Per Share (EPS) is $0.73. On average, analysts forecast that ATRA's EPS will be -$0.89 for 2025, with the lowest EPS forecast at -$3.50, and the highest EPS forecast at $1.72. In 2026, ATRA's EPS is forecast to hit $0.26 (min: -$0.35, max: $0.87).

What is ATRA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ATRA) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.